Fangzhou Inc. stock analysis
Want to see HK:6086 full AI Analyst Report?
Fangzhou Inc. (6086) Stock Price & Analysis
6086 Stock Chart & Stats
- Day’s Range
- HKD 1.01 - HKD 1.08
- 52-Week Range
- HKD 0.63 - HKD 4.33
- Previous Close
- HKD 1.00
- Volume
- N/A
- Average Volume (3M)
- 259.95K
- Market Cap
- HKD 1.45B
- Enterprise Value
- HKD 376.38M
- Total Cash (Recent Filing)
- HKD 505.18M
- Total Debt (Recent Filing)
- HKD 22.88M
- Price to Earnings (P/E)
- 141.8
- Beta
- 1.81
- Next Earnings
- Mar 19, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
Revenue growth of approximately 19% demonstrates expanding activity across Fangzhou’s online healthcare and digital health platforms. Sustained top-line expansion can improve operating leverage, broaden the user and healthcare-participant base, and provide a stronger foundation for future earnings growth.
Return To Profitability
Returning to positive operating profit and net income after sizable losses in 2023–2024 marks a meaningful improvement in the business trajectory. If maintained, profitability can support internal investment, reduce reliance on external financing, and make the operating model more resilient.
Cash Generation
Solid positive operating cash flow and free cash flow indicate that the 2025 improvement was supported by cash generation rather than accounting earnings alone. This strengthens financial flexibility and gives Fangzhou greater capacity to fund operations and strategic development internally.
Bears Say
Thin And Declining Margins
Very thin net profitability leaves limited room for execution setbacks, cost increases, or weaker demand to be absorbed. The decline in gross margin versus earlier years also suggests that revenue growth is not yet translating into durable pricing power or stronger operating economics.
Historical Balance-Sheet Volatility
Historical periods of negative equity indicate that Fangzhou’s financial structure has not been consistently stable, even though leverage improved and equity was positive in 2025. A renewed earnings setback could therefore increase recapitalization and financial-structure risks.
Inconsistent Cash Conversion
Positive 2025 free cash flow is encouraging, but the sharp decline in its growth rate and inconsistency across years make cash generation less dependable as a long-term strength. Volatility could constrain investment planning and reduce flexibility during weaker operating periods.
Fangzhou Inc. News
6086 FAQ
What was Fangzhou Inc.’s price range in the past 12 months?
What is Fangzhou Inc.’s market cap?
When is Fangzhou Inc.’s upcoming earnings report date?
How were Fangzhou Inc.’s earnings last quarter?
Is Fangzhou Inc. overvalued?
Does Fangzhou Inc. pay dividends?
What is Fangzhou Inc.’s EPS estimate?
How many shares outstanding does Fangzhou Inc. have?
What happened to Fangzhou Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Fangzhou Inc.?
What is the TipRanks Smart Score and how is it calculated?
Fangzhou Inc. Stock Smart Score
Company Description
Fangzhou Inc.
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Haijiao Wang
- Employees
- 494
- Website
- Jianke.com
- Address
- Building S, Kehui Jingu, Guangzhou, GD, 510663, CN
Fangzhou Inc. (6086) Earnings & Revenues
6086 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 10 | 6 | 6 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 6 | 0 | 6 |









